• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测评分在耐碳青霉烯类肺炎克雷伯菌感染患者管理中的应用。

The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection.

机构信息

a Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico Sant'Orsola Malpighi , University of Bologna , Bologna , Italy.

b Infectious Diseases Unit, Hospital Universitario Virgen Macarena-Instituto de Biomedicina de Sevilla (IBiS) and Department of Medicine , Universidad de Sevilla , Sevilla , Spain.

出版信息

Expert Rev Anti Infect Ther. 2019 Apr;17(4):265-273. doi: 10.1080/14787210.2019.1595590. Epub 2019 Mar 27.

DOI:10.1080/14787210.2019.1595590
PMID:30876375
Abstract

Carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections are associated with high morbidity and mortality rates. A therapeutic approach based on the patient risk stratification could improve outcome and avoid antibiotic misuse. Areas covered: English literature search, from 2008 to 2018, was done using PubMed database. Risk factors for developing CR-KP infection in several settings were reviewed. Since, rectal carriage was a main risk factor for developing infection, we revised in deep clinical score to predict infection among colonized patients. Furthermore, we investigated overall and treatment-related risk factors for poor outcome in patients with CR-KP infection, in particular the carbapenem producing Enterobacteriacieae (CPE)-INCREMENT score. Finally, an algorithm, based on such scores, for the therapeutic management of patients with CR-KP colonization was commented. Expert opinion: The therapeutic approach analyzed in this review could help physicians to avoid antibiotic overuse as well as to start promptly with the most appropriate antibiotic regimen. However, it has to be validated in further studies, mainly among special population such as immunocompromised patients. The availability of new drugs, fast microbiology, and analysis of gut microbiome could significantly improve the management of CR-KP colonized and/or infected patients.

摘要

耐碳青霉烯类肺炎克雷伯菌(CR-KP)感染与高发病率和死亡率相关。基于患者风险分层的治疗方法可以改善预后并避免抗生素滥用。

涵盖领域

使用 PubMed 数据库进行了 2008 年至 2018 年的英文文献检索。综述了在不同环境中导致 CR-KP 感染的危险因素。由于直肠携带是发生感染的主要危险因素,因此我们深入研究了预测定植患者感染的临床评分。此外,我们研究了 CR-KP 感染患者不良预后的总体和治疗相关危险因素,特别是产碳青霉烯类肠杆菌科细菌(CPE)-INCREMENT 评分。最后,基于这些评分,对 CR-KP 定植患者的治疗管理算法进行了评论。

专家意见

本综述中分析的治疗方法可以帮助医生避免抗生素过度使用,并及时采用最合适的抗生素治疗方案。然而,这需要在进一步的研究中进行验证,特别是在免疫功能低下等特殊人群中。新药物的出现、快速微生物学和肠道微生物组分析可以显著改善 CR-KP 定植和/或感染患者的管理。

相似文献

1
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection.预测评分在耐碳青霉烯类肺炎克雷伯菌感染患者管理中的应用。
Expert Rev Anti Infect Ther. 2019 Apr;17(4):265-273. doi: 10.1080/14787210.2019.1595590. Epub 2019 Mar 27.
2
Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand.泰国一家大学医院抗菌药物使用量与耐碳青霉烯类大肠杆菌及耐碳青霉烯类肺炎克雷伯菌流行率之间的相关性
J Clin Pharm Ther. 2019 Apr;44(2):292-299. doi: 10.1111/jcpt.12791. Epub 2018 Dec 21.
3
Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.耐碳青霉烯类肺炎克雷伯菌(CR-KP)感染对肾移植的影响。
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12757. Epub 2017 Sep 28.
4
Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.口服庆大霉素治疗血液系统疾病患者耐碳青霉烯类肺炎克雷伯菌肠道定植:单中心经验
New Microbiol. 2017 Jul;40(3):161-164. Epub 2017 May 17.
5
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.直肠定植携带碳青霉烯类耐药肺炎克雷伯菌血流感染的危险因素:一项前瞻性观察性多中心研究。
Clin Microbiol Infect. 2014 Dec;20(12):1357-62. doi: 10.1111/1469-0691.12747. Epub 2014 Aug 11.
6
Clinical factors predicting persistent carriage of Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients with known carriage.临床因素预测已知定植携带产碳青霉烯酶肺炎克雷伯菌碳青霉烯耐药肠杆菌科患者中持续定植的情况。
J Hosp Infect. 2018 Aug;99(4):405-412. doi: 10.1016/j.jhin.2017.10.017. Epub 2017 Oct 27.
7
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.含高剂量碳青霉烯类药物联合治疗对耐碳青霉烯类肺炎克雷伯菌血流感染患者死亡率的影响。
Int J Antimicrob Agents. 2018 Feb;51(2):244-248. doi: 10.1016/j.ijantimicag.2017.08.019. Epub 2017 Aug 24.
8
The correlation between intestinal colonization and infection of carbapenem-resistant Klebsiella pneumoniae: A systematic review.肠定植与耐碳青霉烯类肺炎克雷伯菌感染的相关性:系统评价。
J Glob Antimicrob Resist. 2024 Sep;38:187-193. doi: 10.1016/j.jgar.2024.04.013. Epub 2024 May 21.
9
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing .头孢他啶-阿维巴坦对产碳青霉烯酶的. 的体外和体内杀菌活性。
Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018.
10
Clinical and molecular epidemiologic characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonization among neonates in China.中国新生儿耐碳青霉烯类肺炎克雷伯菌感染/定植的临床和分子流行病学特征。
J Hosp Infect. 2018 Sep;100(1):21-28. doi: 10.1016/j.jhin.2018.05.005. Epub 2018 May 12.

引用本文的文献

1
Laboratory detection of carbapenemases among Gram-negative organisms.革兰氏阴性菌中碳青霉烯酶的实验室检测
Clin Microbiol Rev. 2024 Dec 10;37(4):e0005422. doi: 10.1128/cmr.00054-22. Epub 2024 Nov 15.
2
Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making.脓毒症管理:个体化决策背景下抗生素治疗的难题
J Pers Med. 2024 Jan 18;14(1):106. doi: 10.3390/jpm14010106.
3
A clinical predictive model for pre-transplantation colonization and relevance for clinical outcomes in patients receiving allogeneic hematopoietic stem cell transplantation.
一种用于异基因造血干细胞移植患者移植前定植的临床预测模型及其与临床结局的相关性。
Microbiol Spectr. 2024 Feb 6;12(2):e0203923. doi: 10.1128/spectrum.02039-23. Epub 2024 Jan 8.
4
Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation.用于对癌症和造血干细胞移植患者耐碳青霉烯类肠杆菌科菌血症风险进行分层的临床评分系统的开发
Antibiotics (Basel). 2023 Jan 20;12(2):226. doi: 10.3390/antibiotics12020226.
5
Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality.十年耐碳青霉烯类肺炎克雷伯菌血流感染经验:早期恰当经验性治疗对死亡率的影响
Biomedicines. 2022 Dec 16;10(12):3268. doi: 10.3390/biomedicines10123268.
6
The role of cefiderocol in clinical practice.头孢地尔在临床实践中的作用。
Rev Esp Quimioter. 2022 Sep;35 Suppl 2(Suppl 2):39-44. doi: 10.37201/req/s02.06.2022. Epub 2022 Oct 4.
7
Prognostic Significance of the Relative Load of KPC-Producing Klebsiella pneumoniae within the Intestinal Microbiota in a Prospective Cohort of Colonized Patients.定植患者前瞻性队列中肠内共生菌中产 KPC 肺炎克雷伯菌相对负荷的预后意义。
Microbiol Spectr. 2022 Aug 31;10(4):e0272821. doi: 10.1128/spectrum.02728-21. Epub 2022 Jun 29.
8
Clinical Observation and Prognostic Analysis of Patients With Bloodstream Infection.血流感染患者的临床观察与预后分析。
Front Cell Infect Microbiol. 2020 Nov 9;10:577244. doi: 10.3389/fcimb.2020.577244. eCollection 2020.
9
Risk Factors for Subsequential Carbapenem-Resistant Clinical Infection Among Rectal Carriers with Carbapenem-Resistant .耐碳青霉烯类直肠携带者后续发生耐碳青霉烯类临床感染的危险因素
Infect Drug Resist. 2020 May 5;13:1299-1305. doi: 10.2147/IDR.S247101. eCollection 2020.
10
Fecal Carriage and Epidemiology of Carbapenem-Resistant Among Hospitalized Patients in a University Hospital.某大学医院住院患者中耐碳青霉烯类药物的粪便携带情况及流行病学研究
Infect Drug Resist. 2019 Dec 20;12:3935-3942. doi: 10.2147/IDR.S233795. eCollection 2019.